Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity

Journal of Experimental Medicine

Volumn 208, Issue 18, 2011, Pages 1683-1694

  Wei, Joyce ^a   Loke, P'ng ^b   Zang, Xingxing ^c   Allison, James P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; PROTEIN B7X; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 2; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-17; ISLETS OF LANGERHANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN;

EID: 79961147546     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100639     Document Type: Article

References (55)

1. Ando, D.G., J. Clayton, D. Kono, J.L. Urban, and E.E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132-143.
2. Ansari, M.J., A.D. Salama, T. Chitnis, R.N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S.J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63-69.
3. Awadallah, N.S., K.R. Shroyer, D.A. Langer, K.C. Torkko, Y.K. Chen, J.S. Bentz, J. Papkoff, W. Liu, S.R. Nash, and R.J. Shah. 2008. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas. 36:200-206.
4. Ben-Nun, A., H. Otmy, and I.R. Cohen. 1981. Genetic control of autoimmune encephalomyelitis and recognition of the critical nonapeptide moiety of myelin basic protein in guinea pigs are exerted through interaction of lymphocytes and macrophages. Eur. J. Immunol. 11:311-316.
5. Bending, D., H. De la Peña, M. Veldhoen, J.M. Phillips, C. Uyttenhove, B. Stockinger, and A. Cooke. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119:565-572.
6. Calderon, B., A. Suri, and E.R. Unanue. 2006. In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet betacell killing: studies from an acute model. Am. J. Pathol. 169:2137-2147.
7. Carter, L.L., M.W. Leach, M.L. Azoitei, J. Cui, J.W. Pelker, J. Jussif, S. Benoit, G. Ireland, D. Luxenberg, G.R. Askew, et al. 2007. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182:124-134.
8. Gonzalez, A., J.D. Katz, M.G. Mattei, H. Kikutani, C. Benoist, and D. Mathis. 1997. Genetic control of diabetes progression. Immunity. 7:873-883.
9. Greenwald, R.J., G.J. Freeman, and A.H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-548.
10. Guleria, I., A. Khosroshahi, M.J. Ansari, A. Habicht, M. Azuma, H. Yagita, R.J. Noelle, A. Coyle, A.L. Mellor, S.J. Khoury, and M.H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202:231-237.
11. Hathcock, K.S., G. Laszlo, C. Pucillo, P. Linsley, and R.J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
12. Healey, D., P. Ozegbe, S. Arden, P. Chandler, J. Hutton, and A. Cooke. 1995. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979-2985.
13. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199:1479-1489.
14. Hurwitz, A.A., T.J. Sullivan, R.A. Sobel, and J.P. Allison. 2002. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl. Acad. Sci. USA. 99:3013-3017.
15. Jain, R., D.M. Tartar, R.K. Gregg, R.D. Divekar, J.J. Bell, H.H. Lee, P. Yu, J.S. Ellis, C.M. Hoeman, C.L. Franklin, and H. Zaghouani. 2008. Innocuous IFN? induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205:207-218.
16. Jiang, J., Y. Zhu, C. Wu, Y. Shen, W. Wei, L. Chen, X. Zheng, J. Sun, B. Lu, and X. Zhang. 2010. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunol. Immunother. 59:1707-1714.
17. Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1089-1100.
18. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science. 268:1185-1188.
19. Keir, M.E., and A.H. Sharpe. 2005. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204:128-143.
20. Keir, M.E., S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, L.A. Albacker, M. Koulmanda, G.J. Freeman, M.H. Sayegh, and A.H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883-895.
21. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496-2505.
22. Khoury, S.J., W.W. Hancock, and H.L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355-1364.
23. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566-573.
24. Krambeck, A.E., R.H. Thompson, H. Dong, C.M. Lohse, E.S. Park, S.M. Kuntz, B.C. Leibovich, M.L. Blute, J.C. Cheville, and E.D. Kwon. 2006. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc. Natl. Acad. Sci. USA. 103:10391-10396.
25. Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
26. Liang, S.C., Y.E. Latchman, J.E. Buhlmann, M.F. Tomczak, B.H. Horwitz, G.J. Freeman, and A.H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33:2706-2716.
27. Liblau, R.S., S.M. Singer, and H.O. McDevitt. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:34-38.
28. Lühder, F., P. Höglund, J.P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427-432.
29. Martin-Orozco, N., Y. Chung, S.H. Chang, Y.H. Wang, and C. Dong. 2009. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 39:216-224.
30. Mensah-Brown, E.P., A. Shahin, M. Al-Shamisi, X. Wei, and M.L. Lukic. 2006. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur. J. Immunol. 36:216-223.
31. Merrill, J.E., D.H. Kono, J. Clayton, D.G. Ando, D.R. Hinton, and F.M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptideinduced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:574-578.
32. Miljkovic, D., I. Cvetkovic, M. Momcilovic, D. Maksimovic-Ivanic, S. Stosic-Grujicic, and V. Trajkovic. 2005. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell. Mol. Life Sci. 62:2658-2668.
33. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093-1099.
34. Mueller, R., L.M. Bradley, T. Krahl, and N. Sarvetnick. 1997. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity. 7:411-418.
35. Nikoopour, E., J.A. Schwartz, K. Huszarik, C. Sandrock, O. Krougly, E. Lee-Chan, and B. Singh. 2010. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes. J. Immunol. 184:4779-4788.
36. O'Connor, R.A., C.T. Prendergast, C.A. Sabatos, C.W. Lau, M.D. Leech, D.C. Wraith, and S.M. Anderton. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181:3750-3754.
37. Pakala, S.V., M. Chivetta, C.B. Kelly, and J.D. Katz. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J. Exp. Med. 189:1053-1062.
38. Pentcheva-Hoang, T., E. Corse, and J.P. Allison. 2009. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol. Rev. 229:67-87.
39. Perrin, P.J., J.H. Maldonado, T.A. Davis, C.H. June, and M.K. Racke. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333-1336.
40. Petroff, M.G., and A. Perchellet. 2010. B7 family molecules as regulators of the maternal immune system in pregnancy. Am. J. Reprod. Immunol. 63:506-519.
41. Prasad, D.V., S. Richards, X.M. Mai, and C. Dong. 2003. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 18:863-873.
42. Quandt, D., E. Fiedler, D. Boettcher, W.Ch. Marsch, and B. Seliger. 2011. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response. Clin. Cancer Res. 17:3100-3111.
43. Renno, T., M. Krakowski, C. Piccirillo, J.Y. Lin, and T. Owens. 1995. TNFalpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154:944-953.
44. Sica, G.L., I.H. Choi, G. Zhu, K. Tamada, S.D. Wang, H. Tamura, A.I. Chapoval, D.B. Flies, J. Bajorath, and L. Chen. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:849-861.
45. Simon, I., D. Katsaros, I. Rigault de la Longrais, M. Massobrio, A. Scorilas, N.W. Kim, M.J. Sarno, R.L. Wolfert, and E.P. Diamandis. 2007. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. Gynecol. Oncol. 106:334-341.
46. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-1465.
47. Tarbell, K.V., S. Yamazaki, K. Olson, P. Toy, and R.M. Steinman. 2004. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467-1477.
48. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204:191-201.
49. Tringler, B., W. Liu, L. Corral, K.C. Torkko, T. Enomoto, S. Davidson, M.S. Lucia, D.E. Heinz, J. Papkoff, and K.R. Shroyer. 2006. B7-H4 overexpression in ovarian tumors. Gynecol. Oncol. 100:44-52.
50. Wang, B., I. André, A. Gonzalez, J.D. Katz, M. Aguet, C. Benoist, and D. Mathis. 1997. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:13844-13849.
51. Wang, X., J. Hao, D.L. Metzger, A. Mui, Z. Ao, C.B. Verchere, L. Chen, D. Ou, and G.L. Warnock. 2009. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation. 87:482-490.
52. Yuan, C.L., J.F. Xu, J. Tong, H. Yang, F.R. He, Q. Gong, P. Xiong, L. Duan, M. Fang, Z. Tan, et al. 2009. B7-H4 transfection prolongs beta-cell graft survival. Transpl. Immunol. 21:143-149.
53. Zang, X., P. Loke, J. Kim, K. Murphy, R. Waitz, and J.P. Allison. 2003. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA. 100:10388-10392.
54. Zang, X., R.H. Thompson, H.A. Al-Ahmadie, A.M. Serio, V.E. Reuter, J.A. Eastham, P.T. Scardino, P. Sharma, and J.P. Allison. 2007. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc. Natl. Acad. Sci. USA. 104:19458-19463.
55. Zhu, B., I. Guleria, A. Khosroshahi, T. Chitnis, J. Imitola, M. Azuma, H. Yagita, M.H. Sayegh, and S.J. Khoury. 2006. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176:3480-3489.